BAIARDI, GIAMMARCO
 Distribuzione geografica
Continente #
EU - Europa 869
AS - Asia 57
SA - Sud America 12
NA - Nord America 2
AF - Africa 1
Totale 941
Nazione #
IT - Italia 864
CN - Cina 26
VN - Vietnam 15
SG - Singapore 8
BR - Brasile 7
AR - Argentina 3
HK - Hong Kong 3
ID - Indonesia 3
EC - Ecuador 2
NL - Olanda 2
RU - Federazione Russa 2
BD - Bangladesh 1
FI - Finlandia 1
IN - India 1
KE - Kenya 1
SV - El Salvador 1
US - Stati Uniti d'America 1
Totale 941
Città #
Genoa 688
Vado Ligure 155
Rapallo 16
Beijing 11
Ho Chi Minh City 8
Bordighera 3
Hong Kong 3
Singapore 3
Araçatuba 1
Banyuwangi 1
Biên Hòa 1
Camaragibe 1
Córdoba 1
Da Nang 1
Draper 1
Guangzhou 1
Guayaquil 1
Hanoi 1
Humaitá Municipality 1
Hải Dương 1
Jaú 1
Jiaxing 1
Kiambu 1
Manacapuru 1
Milan 1
Mumbai 1
Novosibirsk 1
Phủ Lý 1
Quito 1
Ranchillos 1
Recife 1
Rome 1
Rosario 1
San Salvador 1
Sidoarjo 1
São Paulo 1
Thái Bình 1
Vũng Tàu 1
Totale 917
Nome #
Ceftobiprole quantification in human serum by HPLC-UV to implement routine TDM in clinical practice 85
Dose optimization and target attainment of vancomycin in children 77
The Clinical Efficacy of Multidose Oritavancin: A Systematic Review 74
A Novel LC-MS/MS Method for Therapeutic Drug Monitoring of Baricitinib in Plasma of Pediatric Patients 73
Development and Validation of a Novel LC-MS/MS Method for a TDM-Guided Personalization of HSCT Conditioning with High-Dose Busulfan in Children 71
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method 67
Long-Term Neuroradiological and Clinical Evaluation of NBIA Patients Treated with a Deferiprone Based Iron-Chelation Therapy 66
Altered plasma levels of apixaban in major gastrointestinal tract surgery: A case report and review of the literature 55
Deprescribing Strategies: A Prospective Study on Proton Pump Inhibitors 54
A NOVEL LC–MS/MS METHOD FOR THERAPEUTIC DRUG MONITORING OF APIXABAN IN PLASMA AND DRIED PLASMA SPOT: A POTENTIAL TOOL FOR THE OPTIMIZATION OF DIRECT ANTICOAGULANT DRUGS IN SPECIAL POPULATIONS 48
QUANTIFICATION OF IVACAFTOR, TEZACAFTOR, AND ELEXACAFTOR IN PLASMA OF CYSTIC FIBROSIS PATIENTS BY AN HPLC–MS/MS METHOD 48
Clinical care pathway appropriateness of the intoxicated paediatric patient: a retrospective evaluation with Poisoning Severity Score 47
Prescriptive Appropriateness: Inhospital Adherence to Proton Pump Inhibitors Deprescription Flow Chart 46
Safety and efficacy of ketorolac continuous infusion for multimodal analgesia of vaso-occlusive crisis in patients with sickle cell disease 44
Dried plasma spot as an innovative approach to therapeutic drug monitoring of apixaban: Development and validation of a novel liquid chromatography-tandem mass spectrometry method 42
Multidose Dalbavancin Population Pharmacokinetic Analysis for Prolonged Target Attainment in Patients Requiring Long-Term Treatment 30
Long-Acting Antibiotics: New Opportunities Beyond Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)! 26
Liquid Chromatography-Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Dalbavancin in Plasma of Pediatric and Young Adult Patients 25
Totale 978
Categoria #
all - tutte 4.001
article - articoli 3.625
book - libri 0
conference - conferenze 376
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.002


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202325 0 0 0 0 1 0 0 2 8 4 9 1
2023/2024123 0 8 6 26 4 10 9 5 2 16 7 30
2024/2025503 29 23 32 19 25 46 27 77 48 48 72 57
2025/2026327 119 27 67 64 50 0 0 0 0 0 0 0
Totale 978